Back
Open Access

Effects of intravenous IRON supplementation in Heart Failure with Preserved Ejection Fraction (IRON-HFpEF): a comprehensive multicenter phase 2 randomized clinical trial

Session: Diuretics and intravenous iron and more
Topic: Pharmacotherapy
Speaker: Mr S. Nassiri (Amsterdam, NL)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Mr Soufiane Nassiri

Amsterdam (Netherlands (The))
0 follower

3 more presentations in this session

Medical treatment implementation in ambulatory patients with HF: preliminary data from the nationwide BRING-UP3 HF study

Speaker: Doctor E. D'Elia (Bergamo, IT)

Access
Abstract
Like
Thumbnail

Withdrawal of neurohumoral blockade in patients with normalized ejection fractions after cardiac resynchronization therapy: long-term follow-up of the STOP-CRT trial

Speaker: Doctor M. Van Es (Genk, BE)

Access
Abstract
Like
Thumbnail

Acetazolamide for ambulatory heart failure patients with diuretic resistance.

Speaker: Doctor P. Gil Martinez (Madrid, ES)

Access
Abstract
Like
Thumbnail

Access the full session

Diuretics and intravenous iron and more

Speakers: Mr S. Nassiri, Doctor E. D'Elia, Doctor M. Van Es, Doctor P. Gil Martinez
Access
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources